http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2538646-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ee6a025faf92a7638aa1863949d04f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e01290e9d1b84b4ddf45d01f66c58d8c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
filingDate | 2013-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c9a220628088fb25293de34b31a9c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23dd725acabaeca698dcaffed76dc02c |
publicationDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2538646-C1 |
titleOfInvention | Method for bioencapsulation |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for producing drug microcapsules by non-solvent addition, differing by the fact that the drugs are presented by cephalosporin preparations, while the coating is human leukocyte interferon α and β, which is deposited from an aqueous solution by adding isopropanole as a non-solvent and acetone at 25°C. n EFFECT: invention provides simplifying and accelerating the process of microcapsules, reducing production loss (higher mass yield). n 4 ex |
priorityDate | 2013-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.